10.1038/29087 Nature 19 DelledonneM.ZeierJ.MaroccoA.LambC
Serious side effects may include allergic reaction
Diabetes 49 , 589596 (2000)
The key milestones include: exenatide approval (2005), liraglutide approval (2010), semaglutide injection approval (2017), oral semaglutide with SNAC approval (2019), orforglipron cryo-EM structure published (2020), orforglipron Phase 2 results in NEJM (2023), orforglipron Phase 3 ATTAIN-1 results in NEJM (2025), and FDA regulatory submission (2025)
Posted January 08, 2026 in Fertility Blog & Information 17 minute read Key Takeaways BPC-157 can potentially support reproductive health by decreasing inflammation and aiding tissue repair, especially for specific conditions that can impact conception and pregnancy
The potential regulatory nature of K glu was supported by observations that dietary tryptophan supplementation alters K glu , and that SIRT5 can act as a protein deglutarylating enzyme 5,12